z-logo
open-access-imgOpen Access
Efficacy of antidepressants: similar but different
Author(s) -
Paul Matthews
Publication year - 2011
Publication title -
the international journal of neuropsychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 107
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1017/s1461145711000551
Subject(s) - placebo , expectancy theory , venlafaxine , paroxetine , hamd , antidepressant , rating scale , psychology , psychiatry , depression (economics) , hamilton rating scale for depression , clinical psychology , medicine , major depressive disorder , anxiety , mood , alternative medicine , developmental psychology , social psychology , macroeconomics , pathology , economics
Fountoulakis & Moller (2010) have re-analysed the Kirsch et al. (2008) meta-analysis of newer antidepressants and reached quite different conclusions to the original study. In particular they highlight that both venlafaxine and paroxetine exceed the NICE criteria for ‘clinical significance’ of 3 points on the Hamilton Rating Scale for Depression (HAMD) and that the Kirsch et al. analysis underestimates the effect size of newer antidepressants due to methodological reasons. They also go on to claim that placebo response in trials declines with increasing baseline severity while antidepressant response remains the same. They argue this means that while much of the placebo response is due to expectancy effect this is not true for antidepressants and that therefore the effects are not additive, undermining the validity of randomized controlled trials.We have also performed a re-analysis of the Kirsch et al. data (Horder et …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom